Oxidative Stress in AgingView this Special Issue
Oxidative Stress in Aging: Advances in Proteomic Approaches
Aging is a gradual, complex process in which cells, tissues, organs, and the whole organism itself deteriorate in a progressive and irreversible manner that, in the majority of cases, implies pathological conditions that affect the individual’s Quality of Life (QOL). Although extensive research efforts in recent years have been made, the anticipation of aging and prophylactic or treatment strategies continue to experience major limitations. In this review, the focus is essentially on the compilation of the advances generated by cellular expression profile analysis through proteomics studies (two-dimensional [2D] electrophoresis and mass spectrometry [MS]), which are currently used as an integral approach to study the aging process. Additionally, the relevance of the oxidative stress factors is discussed. Emphasis is placed on postmitotic tissues, such as neuronal, muscular, and red blood cells, which appear to be those most frequently studied with respect to aging. Additionally, models for the study of aging are discussed in a number of organisms, such as Caenorhabditis elegans, senescence-accelerated probe-8 mice (SAMP8), naked mole-rat (Heterocephalus glaber), and the beagle canine. Proteomic studies in specific tissues and organisms have revealed the extensive involvement of reactive oxygen species (ROS) and oxidative stress in aging.
Despite the great research efforts performed since molecular techniques have emerged, it is unquestionable that the step-by-step approach of studying one gene or one protein at a time, even if their partners could eventually be unveiled, is a parsimonious endeavor. Therefore, a more integral and holistic approach is required. Within this context, genomic and proteomic studies, mainly by microarray for messenger RNA (mRNA) and two-dimensional (2D) electrophoresis for protein expression profiles, would eventually elicit the comprehension of the entire process of cell function, and also that at tissue and organ levels, which in turn will provide us with a wider panorama and lead us to a more comprehensive understanding of the aging mechanisms and the intrinsic role of reactive oxygen species (ROS) at a molecular level.
Both approaches yield a large amount of information from every group of cells, tissue, or organ condition, both in vivo and in vitro, under certain circumstances, and at a particular developmental time. In this review, we present a compilation of advances of the influence of oxidative stress during aging, obtained by means of a proteomic approach in different cellular types, tissue types, or animal models. The second major global approach for expression analysis, by gene expression profile by microarrays, will be reviewed elsewhere.
The existence of free radicals, such as chemical entities, was inferred 100 years ago, but their importance in biological systems was not recognized until the mid-1950s; nonetheless, for the majority of the remaining 20th century, ROS were considered “a type of biochemical rusting agent that caused stochastic tissue damage and disease” . Now, in the 21st century, reactive oxygen biochemistry is quite relevant among the biomedical sciences, and it is currently recognized that nearly every disease involves some degree of oxidative stress. Additionally, it is recognized that ROS are produced in a well-regulated manner to help maintain homeostasis at the cellular level in normal, healthy tissue ; but, when ROS concentrations exceed the cell’s antioxidant capacity, severe damage can occur and the organism experiences oxidative stress . The damaging effects of these concentrations have been implicated in aging [3, 4], and also in neurodegenerative diseases such as Alzheimer’s disease and Parkinson’s disease, and in other chronic and degenerative diseases such as cancer, atherosclerosis, diabetes, and heart disease .
As early as 1956, Denham Harman proposed the “Free Radical Theory of Aging” ; additionally, other studies from Gilbert, Chance, and Commoner can be considered as the “founders” of reactive oxygen biochemistry. However, by 1980, oxyradicals were accepted biological entities, though their significance for aging and disease remained generally unappreciated . Around 1980, the Stadtman group began to investigate the nature and consequences of protein oxidation in vitro and in vivo. These authors measured protein carbonyl groups as indices of oxidative damage and applied these techniques to the study of protein oxidation in aging tissue, describing the first, detailed determinations of protein oxidation in models of human aging [7, 8] and giving rise to serious consideration of oxidative stress as a pathological factor.
The application of genomics, proteomics, and even metabolomics to the research on aging, as well as the study of epigenetic influences that are able to induce histone and DNA modifications and influence enzyme activity, would increase our understanding of the origin and development of the different process that contributes to this unavoidable life consequence, senescence. Epigenetic mechanisms are typically associated with the aging process and age-related diseases and may have significant roles to play in the presence of oxidative stress during aging, thereby enabling the establishment of specific diagnostic profiles and therapeutic templates that could aid in improving Quality of Life (QOL) at advanced ages (for a striking revision regarding the relationship between epigenetic factors and aging, see ).
2. Global Approaches to the Study of Oxidative Stress in Aging at the Molecular Level
One of the major goals of Gerontology is to understand the complex mechanisms involved in aging at the molecular, cellular, and organ levels that would also make the understanding of age-related diseases possible. Because of practical limitations in studying the aging process in humans in vivo, animal models are frequently utilized ; however, differences in longevity between the majority of experimental animal models and humans make analysis somewhat difficult. Despite these limitations, research in this area has accelerated with the application of high-throughput technologies such as microarrays and mass spectrometry (MS). Once applied, the information generated must be analyzed accurately; thus, the use of bioinformatics is highly relevant . One of the great advantages of the study of the proteomic is that the huge amount of information generated by a particular set of experiments, as occurs in genomics studies also, can be deposited in large databases, which in turn would accelerate, in the near future, experimental work and improve the results obtained, particularly in the study of aging as a comprehensive biological phenomenon (Figure 1). While aging has been considered a stochastic process, widespread opinion at present takes into account the existence of a strictly regulated system that fine-tunes the lifespan of an organism through modulation of its responses to oxidative stress .
Research on ROS and oxidative stress has become a rapidly growing and evolving subject of study. Specifically in the field of aging studies, a review of the PubMed database (http://www.ncbi.nlm.nih.gov/) under the terms (“oxidative stress” OR “reactive oxygen species”) AND aging AND microarray or (“oxidative stress” OR “reactive oxygen species”) AND aging AND proteomic (both restricted to title/abstract search fields) shows the increasing interest in these integral molecular approaches during the last decade.
It is relevant to bear in mind the relevance of posttranslational modifications that regulate the activity of proteins inside the cell. Thus, the number of distinct protein functionalities exceeds the number of protein sequences and concentrations; therefore, one must establish the relative concentration, location, and posttranslational modification of each isoform in order to completely characterize protein function.
3. Accumulation of Altered Posttranslational Modifications and Lack of Adequate Protein Degradation Are Involved in Aging
During the normal aging process and also in age-related diseases such as atherosclerosis, cataracts, type 2 diabetes, and neurodegenerative diseases, proteins are the targets of several posttranslational deleterious modifications that alter their biological functions (Table 1). ROS increase oxidative stress [13–15] and reactive nitrogen species (RNS) yield nitrosative stress . Together, as well as in conjunction with other toxic compounds, such as dicarbonyl and reactive aldehydes, which are mainly responsible for this damage [16, 17], which in several cases translates into clinical pathology.
Additionally, protein degradation is integral for maintaining a healthy and functional proteome, particularly for turning over misfolded and damaged proteins. Removal of oxidized proteins first involves selective recognition of the modification and afterward, either their repair or their degradation . Protein concentration increases with both decreased degradation and increased synthesis; yet, while decreased degradation results in the accumulation of “old” proteins, increased synthesis does not . Thus, the age-related accumulation of damaged proteins is thought to result from both the increased occurrence of damage, which is due, at least in part, to alterations in the detoxification of the damaging agents, and from the decreased efficiency of the different systems involved in the elimination of damaged proteins . This relationship is illustrated in Figure 2.
Protein quality, but not necessarily quantity, is altered in a disease state and can be reversed by appropriate treatment. This has been demonstrated, for example, in the case of apolipoprotein A1 (ApoA1) in type 1 diabetes, in which ApoA-1 proteins acutely acquired damage during insulin deprivation, providing a feasible mechanism for the association between chronically poor glycemic control and higher levels of protein oxidation in diabetes . In fact, it may be that this rapid aging of ApoA-1, a key protein in lipoprotein metabolism, causes a higher risk of macrovascular disease in persons with type 1 diabetes . Therefore, it has been proposed that aging, as well as certain pathologies such as diabetes, insulin resistance, and metabolic syndrome, are caused in part by the disproportionate accumulation of damaged and dysfunctional proteins, rather than by their increased concentration per se, by the impairing of cellular degradation systems, whereby oxidized proteins that would normally be targeted for degradation accumulate due to age-related slowing of degradation pathways, which are easily overwhelmed by an excess of posttranslational stress [19, 20, 23–28]. Accordingly, observational studies in animals suggest that enhancing protein degradation by caloric restriction and aerobic exercise may retard aging and reverse age-associated pathologies, and it has been hypothesized that caloric restriction helps to modulate the inflammatory process, subsequently leading to the reduction of chronic diseases known to compromise the functional longevity of humans . Notwithstanding this, whether these strategies can promote similar improvements in humans remains to be shown .
Oxidation of proteins targets them for degradation; however, extensive oxidation acts against their recycling because it inhibits proteolysis, leading to pathological accumulation and deposition [28, 30]. Modification of proteins also can modify an active site, block a phosphorylation site, or disrupt a binding site for substrates, cofactors, or partner proteins. Furthermore, it can create new epitopes for antibody recognition and induce autoimmune disorders [31, 32].
Although it is widely recognized that cellular aging causes changes in the proteome, the nature and targets of these changes and their consequences have not yet been completely identified. It is noteworthy that accumulative oxidative posttranslational modifications are relevant only if these detected modifications are connected to functional consequences . But in addition, it is relevant to consider that a slight modification in low abundance proteins may be of physiological importance; therefore, many proteomic studies have been undertaken to identify modified proteins. Distinguishing between inconsequential modifications and functionally significant ones requires careful biochemical and biophysical analysis of target proteins. Thus, proteomic approaches represent powerful tools to address these questions by identifying the targeted proteins and the extent of their modifications.
4. Oxidation of Proteins Directly Affects Energetic and Metabolic Pathways and Is Related to Longevity
Oxidation-reduction (Redox) regulatory control and oxidative stress are two sides of the same coin: oxidation of proteins can modify proteins under reversible Redox regulatory control or, alternatively, can result in reversible or irreversible oxidative damage. Proteins are very sensitive to the action of ROS  and represent nearly 70% of their targeted entities ; in addition, ROS can oxidize membrane lipids, generating intermediary compounds that have a longer lifespan than ROS and that can diffuse into the cell, acting as a “toxic second messenger,” amplifying the damage of free radicals . Recently, systemic Redox regulation has been recognized as a highly important element for longevity in a group of Japanese semisuper centenarians (>105 years of age), who probably escape from many serious chronic and age-related diseases by their ability to deal with a variety of stresses, including oxidative stress .
Therefore, recent proposals tend to prevent, rather than counteract, ROS production, particularly at the mitochondrial level, during oxidative metabolism (the mitochondrial free radical theory of aging) . Although there is evidence that ROS production in the human skeletal muscle is lower in mitochondria from older subjects , adenosine triphosphate (ATP) synthesis was significantly decreased, supporting the concept that aging is associated with a decrease in mitochondrial function, although in this case, ROS production appears to be reduced. In the same study, when older subjects were under a regimen of physical exercise, an improvement was found in their mitochondrial function, as well as a concomitant increase in ROS production , which apparently counteracted the effect of aging at the molecular level with respect to mitochondrial function.
Therefore, these apparently contradictory results can be conciliated on the basis of equilibrium between the amount of ROS generated, which can be beneficial or defective, and the amount of oxidized proteins, depending on the tissue and its metabolic status. As a result of the analysis of cumulative evidences, two general characteristics responsible for the degree of high maintenance of long-lived animals emerge: a low generation rate of endogenous damage and the possession of macromolecules that are highly resistant to oxidative modification .
To detect protein oxidation, carbonyls are the most commonly employed marker, and the use of 2D gel electrophoresis has provided very useful results for the study of specific carbonylated protein spots during oxidative stress and replicative senescence [39, 40]. Although MS is currently the most versatile technology in proteomics for the identification of proteins and their carbonylated residues, some limitations have led to the development of alternative strategies, such as fluorescent probes, which are able to detect lower abundance carbonylated proteins . Additionally, cysteine oxidation became important because these lie precisely at the interface between Redox-sensitive and oxidative damage by ROS or nitrogen species during stress . Interestingly, a highly significant inverse correlation between long lifespan and the percentage of mitochondrial cysteine is found in metaexaminations of genomic sequences (mitochondrial DNA) from 218 animal species (chordates and arthropods) , supporting the previously mentioned free radical theory of aging and point out the relevance of the vulnerability of the proteins in the organism to oxidative stress in terms of its lifespan.
Taking into account the alterations of metabolism in humans, the Cornelia de Lange syndrome is a rare multisystem disorder characterized by distinctive craniofacial dysmorphia, upper limb malformations, hirsutism, microcephaly, cardiac defects, gastroesophageal dysfunction, growth retardation, and neurodevelopment impairment ranging from moderate to severe, with a wide range of variability . Patients present a premature aging process, and it is likely that a reduction in energy and the downregulation of proteins involved in antioxidant and detoxification pathways could lead to premature physiological aging and genome instability .
On the other hand, a possible model of longevity has been described; it is based on the knocking out of type 5 adenylyl cyclase (AC5) . Adenylyl cyclase (AC) is a key enzyme that catalyzes the synthesis of cyclic adenosine monophosphate (cAMP) from ATP and it plays a pivotal role in β-adrenergic receptor signaling. In these AC5 KO mice, activation of the Raf/Mitogen-activated protein kinase/MAP kinase kinase (Raf/MEK/ERK) signaling pathway is present, which in turn promotes the upregulation of Mn-superoxide dismutase (Mn-SOD) and results in protection from oxidative stress and apoptosis, retarding aging phenotypes in the heart and bone and increasing resistance to stress, which leads to longevity in the lifespan, suggesting that retarding aging in an individual organ could be a fundamental therapy to prevent age-related diseases .
Delving deeper into the identification of proteins involved or affected by aging, postmitotic tissues have received more attention. Neurons, myocytes, and red blood cells have been studied during the aging process, and certain particular and some common factors have been discovered. In the following sections, the main advances in proteomics studies of these post-mitotic cells are presented.
5. Proteomic Studies Further Support Parallelism between Aging and Neurodegenerative Diseases
An increase in oxidative stress in the brain is part of normal aging and is related directly to decreased neurological activities and inversely to lifespan . Common pathological pathways that are implicated both in aging and in the development of neurodegenerative disease include free radical damage and decreased energy production as characteristic hallmarks . Consistent with this idea, proteins that increase with aging in the mice hippocampus are mainly enzymes that mediate energy production and oxidative stress . In addition, one of the cellular processes that are altered mainly in the aging hippocampus is that of oxidative stress, as well as that of protein processing .
Consistent with previous ideas, wide proteomic analysis of brains during aging in mice identifies 40 proteins that exhibit changes in their natural pattern during the mouse lifespan (from 4 days to 15 months of age), showing that six proteins increased and 27 decreased in various ways. When analyzed together, the biological processes in which those proteins are involved correspond mainly to the following: protein metabolic processes (more than one third); transport (one third); nucleotide and nucleic acid metabolic process (one fourth); intracellular signal cascade (nearly one fifth), and response to stress proteins (more than one sixth). Additionally, about one fifth of the identified proteins can be localized in the mitochondria and the majority of these are related to energy metabolism , providing a broad panorama of proteomic changes in the brain during aging.
In addition, there is increasing evidence that protein oxidation is involved in the pathogenesis of Alzheimer’s disease (AD), a neurodegenerative disorder associated with cognitive decline, oxidative stress, and aging [52–56]. Two initial studies using the proteomic approach have identified proteins that are specifically oxidized in AD [54, 55]. In the first study, three key enzymes in cellular metabolism, creatine kinase BB (CK BB), glutamine synthase (GS), and ubiquitin carboxy-terminal hydrolase L-1 (UCH L1), resulted as specific targets of protein oxidation in the brain of AD patients. In the second, a couple of additional targets were detected: dihydropyridine-related protein-2 (DRP-2), involved in axonal growth, and α-enolase, involved in glycolysis for energy metabolism and therefore related with the cerebral decrease of energy metabolism. These results strongly suggest that the process of free radical-mediated protein modification may be a crucial event in AD and that protein oxidation is a relevant part of the mechanism of neurodegeneration in AD brain.
Although in a pilot study of abundant carbonylated proteins in the cerebrospinal fluid of probable AD patients the extent of carbonylation did not vary in general, two proteins were detected that were highly carbonylated when compared to controls: immunoglobulin λ light chains and one unidentified protein , which suggests that further studies could be performed focusing on less abundant proteins, modified by oxidative stress, to detect some probable markers of early pathological stages. Therefore, the establishment of differences in protein oxidation state may provide a diagnostic tool for neurodegenerative diseases.
Additionally, Weinreb et al. found a significant parallelism in the protein profile affected between aging and neurodegenerative diseases in the hippocampus of rats . They found that in the aged hippocampus, oxidative stress and mitochondrial dysfunction are important and that in treatment with an anti-AD drug, Ladostigil, or with an anti-Parkinson drug, Rasagiline, both drugs reversed the effect of aging on various mitochondrial and key regulator genes involved in neurodegeneration, cell survival, synaptogenesis, oxidation, and metabolism. Another consequence of oxidative stress in the brain includes the generation of RNS. The cerebellum is especially vulnerable to oxidative stress and exhibits an age-dependent increase of total 3-nitrotyrosine (3-NT) [59, 60], and some proteins have been identified as targets for nitration .
Additionally, in cultured neurons exposed to amyloid beta (Aβ) (1–42), two proteins are significantly oxidized: 14-3-3ξ and glyceraldehyde-3-phosphate dehydrogenase (GAPDH), and pretreatment with γ-glutamylcysteine ethyl ester, a compound that supplies the limiting substrate for antioxidant glutathione synthesis, protects both proteins from oxidation by Aβ 1–42 , which is consistent with the notion that antioxidant therapies may potentially be effective in slowing or ameliorating the neurodegenerative disease process [56, 62].
Conversely, the other cell type that is more abundant in the central nervous system, the glial cells, are more resistant than neurons to oxidative stress and are able to respond to protect them [63–66]. Surprisingly, proteomic studies that focus on the role of glial cells during aging, or in neurodegenerative diseases, in response to oxidative stress are very scarce. Miura et al. proposed that aging does not suppress the astrocytic capability to respond to oxidative stress. The authors found that α-tubulin was subjected to tyrosyl phosphorylation by H2O2-exposure and that aging enhanced this phosphorylation and prevented the formation of microtubules, but aging does not suppress the responses aimed at cell protection against severe oxidative stress . Therefore, proteomic studies on the response of glial cells to oxidative stress during aging and in neurodegenerative diseases, focusing on their helping role for neuron metabolism, represent a promising avenue that is yet to be explored.
6. Aging in Cardiac and Skeletal Muscles Altered Energy Metabolism and Mitochondria
Cardiac performance declines with age  in a clear association with oxidative stress . Accordingly, aging is a factor for cardiovascular disease. It appears that the protein signature or proteomic phenotype that changes during aging in the rodent heart renders the tissue more sensitive to oxidative stress damage with age by modifying the energy metabolism, particularly carbohydrate metabolism, fatty acid oxidation, cellular respiration, and energy production and their capacity to respond to oxidative stress .
In the aged rat heart, several proteins have been identified as differentially expressed when compared with those of young hearts [69–71], although there are many differences among studies, probably derived from methodologically different approaches and species particularities (mouse or rat), also due to the fact that many proteins change consistently during aging. Additionally, a study of a heart failure model, transverse aortic constriction in mice, demonstrated a differentially expressed protein expression of structural, signaling, and redox proteins . Thus, it is possible to establish parallelism between aging heart dynamics and heart failure, both altering structural proteins as well as the oxidative metabolic profile and affecting the heart’s capacity to respond adequately to oxidative stress during aging or under pathological distress.
Among the functional consequences of oxidative stress induced by ROS and RNS on cardiac and skeletal muscle tissue during aging, we find protein nitration , which may affect protein structure, function, and turnover. Thus, the accumulation of nitrated proteins in cardiac and skeletal muscle tissue [74, 75] may define the progress of biological aging or of any pathology.
7. During Red Blood Cell Aging, Hemoglobin-Generated Oxidants That Affect Cellular Membrane and Cytoskeleton
Many of the cell processes associated with the physiological removal of red blood cells (RBC) involve oxidative stress, which is generated by both endogenous hemoglobin (Hb) auto-oxidation and exogenous oxidants, which can result in functional impairment and in cellular aging . The predominant factor that determines oxidative stress in RBC is Hb. The superoxide, H2O2, hydroxyl radicals, ferrylHb, oxoferrylHb, and peroxynitrite generated by redox reactions near the membrane can damage RBC membrane proteins, lipids, and the cytoskeleton, which are responsible for maintaining the RBC shape and deformability, thus being able to damage and promote cellular aging . Consequently, instead of required large concentrations of antioxidants to neutralize the ROS species formed, blocking Hb interaction with the membrane will make it possible to eliminate Hb-generated oxidants, preventing oxidative stress in RBC . In RBC, and due to their extensive use for blood transfusions, their oxidative stress is also highly relevant during long-term storage . Consequently, the proteomic approach has been useful to identify molecular markers, such as Prx2, as a candidate biomarker for RBC oxidative injuries under blood bank conditions , possibly to be utilized in future blood component programs to improve the quality of stored RBC and to limit or avoid the risk of posttransfusional complications.
In brief, and beyond the cell type affected, on the basis of extensive experimental results, the main cellular dysfunctions directly caused by oxidative stress imbalance and by uncontrolled generation of ROS can be summarized as follows (Figure 3). Whether from self-cell metabolism or from extracellular sources generating an uncontrolled increase of ROS and RNS, both of these produce cell damage by modifying proteins (mainly by carbonylation, sulfoxidation, hydroxylation, nitration, and S-thiolation) and avoiding the recycling of these by the proteasome, yielding impaired protein function. Additionally, oxidative stress can directly affect the cellular membrane, causing lipid peroxidation, thus instability, and can also modify cytoskeletal proteins, causing structural damage and moreover altering signaling pathways. Furthermore, oxidative stress directly affects mitochondria and peroxisomes, thereby altering cell metabolism and energy production. Taken together, these alterations would be able, in some manner, to distress nuclear transcription and generate altered gene expression during normal aging, or leading to disease. Although this is a general panorama, there are more specific alterations depending on the cellular type affected or on the tissue or organ altered. Therefore, it is a priority to establish more models to study the whole effect of oxidative stress during aging and disease.
8. Particular Organisms as Alternative Models for Studying the Proteomics of Oxidative Stress during Aging
In addition to the more widely used models employed to study aging (such as rodents like mice or rats, cultured line cells, or even tissue fragments, blood, or serum), other particular organisms represent suitable alternatives for approaching the problem. In Table 2, we summarize some of the main works that, based on their wide proteomic approach, deal with the aging process, selecting those that have obtained results that are clearly related with the involvement of oxidative stress and ROS in the aging process. The following is a brief summary of some particular models and their contribution to elucidating the participation of oxidative stress during aging.
The invertebrate Caenorhabditis elegans has been successfully used to study the aging process. It has been described that some proteins are involved in both cellular senescence and the ROS-induced condition. By using interfering RNA (iRNA) against some genes, a substantial reduction can be caused in adult lifespan, and the defensive mechanism against external oxidative stress is also disturbed . Therefore, some proteins whose expression is increased with cellular senescence and oxidative stress play a protective role against these processes. Additionally, when C. elegans is submitted to oxidative stress through sublethal short-treatment of peroxide (H2O2) stress, the majority of worms experience severe, yet fully reversible, behavioral changes that are highly reminiscent of well-known age-related changes , such as declines in body movement, pharyngeal pumping, and reproduction, as well as morphological changes and reduced metabolic activity , which supports the Harman free radical theory of aging, but would also include the potentially beneficial aspects of ROS as modulatory second messengers that affect stress resistance and longevity early in life . In another example, C. elegans xpa-1 mutants, which are ultraviolet-light (UV)-sensitive and that have reduced capacity to repair UV-induced DNA damage , exhibit oxidative stress and its antioxidant defenses are induced, and they also show polyubiquitinated protein accumulation . Obviously, there are differences between nematode (invertebrate) and mammalian (vertebrate) systems, but the fundamental mechanism of cellular senescence may be evolutionarily conserved.
Another very attractive model for studying the effect of oxidative stress during aging is the senescence-accelerated probe-8 (SAMP8) mouse, which exhibits age-related deterioration in memory and learning, along with an increase in oxidative markers and which is considered a useful model for the study of AD . In AD, it has been demonstrated that treatment with α-lipoic acid, a coenzyme involved in the production of ATP in mitochondria and a potent antioxidant [114, 115], is able to reduce oxidative modification and increase the protein level of α-enolase, suggesting the possibility that the reduced glucose metabolism and neurochemical alterations in SAMP8 mouse brains can be reversed . Additionally, it has been demonstrated that carbonyl modification of Cu, Zn-superoxide dismutase (Cu, Zn-SOD) in liver and hippocampal cholinergic neurostimulating peptide-precursor protein (HCNP-pp) in the brain were higher in SAMP8 compared with the control, SAMR1. Therefore, progressive accumulation of oxidative damage to Cu, Zn-SOD may cause dysfunction of the defense systems against oxidative stress in SAMP8 with higher oxidative states, leading to the acceleration of aging .
A different and very interesting organism for studying the effect of oxidative stress during aging is the naked mole-rat (H. glaber) because it has very low metabolic and respiratory rates and its protein structure and function is not apparently affected by either oxidative stress or carbonylation during aging, probably due to a particular characteristic of the cellular environment that maintains the functional structure of proteins . As an example, activation of the Nuclear factor [(erythroid-derived 2)-like 2] (Nrf2) antioxidant response pathway, which increases the transcription of antioxidant response-element genes, proteasomes, and antioxidants and which affects the efficient maintenance of protein homeostasis, can protect proteins from misfolding or aggregation by oxidative stress [117, 118], being part of a protective cellular environment that efficiently maintains protein homeostasis as part of a potential plausible mechanism that explains the exceptional longevity of the naked mole-rat .
Finally, an attractive model for the aging human brain is the aging beagle (canine) brain, especially also as a model of AD [119–122]. In the aging canine brain, a proteomics study reveals that a combined treatment of antioxidant-fortified food and an enriched environment reduces the levels of oxidative damage, improves the antioxidant reserve systems, increases the activity and expression of key endogenous antioxidant enzymes, and may contribute to improvements in learning and memory .
9. Concluding Remarks
One limitation of some of the reports presented here is that details regarding animal ages, care, and behavior assessments/measures are limited, which impedes cross-study comparison and meta-analyses. Also, cell types and their particular characteristics rendered comparison of the effect of ROS on RBC or neurons difficult, for example, as well as under in vitro or in vivo conditions. Thus, therefore more and wider studies are needed.
In humans, it is difficult to compare among proteomic studies because of insufficient characterization of the study material, the small number of patients involved in studies, and variations in experimental designs. At present, basic aging research has arrived at a pharmaceutical phase, with the testing of novel drugs designed to extend a healthy life by targeting specific biochemical pathways, perhaps in specific organs . In this respect, the National Institute on Aging Interventions Testing Program (ITP) experimentally evaluates chemical compounds with potential senescence-retarding effects that can be administered to mice in food or water . While initial results are far from surprising, the experimental design is robust; therefore, it will be useful in order to develop a similar program in mouse genetics in aging.
It is evident that the sole fact of identifying the whole genome sequence of an organism, or to know the whole isoforms and modifications of its products (proteins), is not sufficient for complete elucidation of the aging process. It is necessary to integrate all of this information in a functional manner that reflects more precisely the real situation. Therefore, as important as the generation of all “omic” information is, the development of instruments to analyze and evaluate this efficiently is equally important. In this regard, bioinformatics and computational biology are devoted to performing these analyses, both based on systems biology, that is, the construction of gene, protein, and metabolic pathway networks that interact among them to constitute functional modules (Figure 1). In turn, they integrate design models for prediction from clinical phenotypes to diagnostic and therapeutic strategies after experimentation takes place. Albeit proteomics has already contributed relevant insights in the field of aging research and attempts have been made, in animal models such as mice to map aging-related brain proteins within the context of the biological processes involved ; a reference mapping of proteins in healthy aging human subjects has yet to be performed. Nonetheless, with the continued advances in proteomic technology, the study of the proteome during aging is entering a brand new phase of discovery.
Conflict of Interests
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interests.
This work was partially supported by Universidad de Guadalajara Grants P3E/2013/218202 and PIE-BKC 2013 (Visiting Lecturers of Excellence) from the University of Barcelona-Barcelona Knowlegde Campus to Daniel Ortuño-Sahagún. This work was also supported by Grants from CONACyT 2012-180268 and PROMEP/103.5/12/8143 to A. E. Rojas-Mayorquín and from Spanish Ministerio de Ciencia e Innovación (SAF2012-39852) to Mercè Pallàs. The authors apologize to authors whose works have not been reviewed and to those whose papers have not received the emphasis that they merit. The authors also apologize to authors whose work has not been appropriately cited due to space limitations and/or to limitations of our knowledge.
K. Hensley and R. A. Floyd, “Reactive oxygen species and protein oxidation in aging: a look back, a look ahead,” Archives of Biochemistry and Biophysics, vol. 397, no. 2, pp. 377–383, 2002.View at: Publisher Site | Google Scholar
J. A. Imlay, “Pathways of oxidative damage,” Annual Review of Microbiology, vol. 57, pp. 395–418, 2003.View at: Publisher Site | Google Scholar
R. S. Sohal, “Role of oxidative stress and protein oxidation in the aging process,” Free Radical Biology and Medicine, vol. 33, no. 1, pp. 37–44, 2002.View at: Publisher Site | Google Scholar
B. J. Merry, “Oxidative stress and mitochondrial function with aging—the effects of calorie restriction,” Aging Cell, vol. 3, no. 1, pp. 7–12, 2004.View at: Publisher Site | Google Scholar
T. Finkel and N. J. Holbrook, “Oxidants, oxidative stress and the biology of ageing,” Nature, vol. 408, no. 6809, pp. 239–247, 2000.View at: Publisher Site | Google Scholar
D. Harman, “Aging: a theory based on free radical and radiation chemistry,” The Journal of Gerontology, vol. 11, no. 3, pp. 298–300, 1956.View at: Publisher Site | Google Scholar
C. N. Oliver, B.-W. Ahn, and E. J. Moerman, “Age-related changes in oxidized proteins,” The Journal of Biological Chemistry, vol. 262, no. 12, pp. 5488–5491, 1987.View at: Google Scholar
C. D. Smith, J. M. Carney, P. E. Starke-Reed et al., “Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease,” Proceedings of the National Academy of Sciences of the United States of America, vol. 88, no. 23, pp. 10540–10543, 1991.View at: Google Scholar
P. Kaliman, M. Párrizas, J. F. Lalanza, A. Camins, R. M. Escorihuela, and M. Pallàs, “Neurophysiological and epigenetic effects of physical exercise on the aging process,” Ageing Research Reviews, vol. 10, no. 4, pp. 475–486, 2011.View at: Publisher Site | Google Scholar
H. Gershon and D. Gershon, “Paradigms in aging research: a critical review and assessment,” Mechanisms of Ageing and Development, vol. 117, no. 1–3, pp. 21–28, 2000.View at: Publisher Site | Google Scholar
C. Raghothama, H. C. Harsha, C. K. Prasad, and A. Pandey, “Bioinformatics and proteomics approaches for aging research,” Biogerontology, vol. 6, no. 4, pp. 227–232, 2005.View at: Publisher Site | Google Scholar
R. Colavitti and T. Finkel, “Reactive oxygen species as mediators of cellular senescence,” IUBMB Life, vol. 57, no. 4-5, pp. 277–281, 2005.View at: Publisher Site | Google Scholar
E. R. Stadtman, “Role of oxidant species in aging,” Current Medicinal Chemistry, vol. 11, no. 9, pp. 1105–1112, 2004.View at: Publisher Site | Google Scholar
V. I. Pérez, R. Buffenstein, V. Masamsetti et al., “Protein stability and resistance to oxidative stress are determinants of longevity in the longest-living rodent, the naked mole-rat,” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 9, pp. 3059–3064, 2009.View at: Publisher Site | Google Scholar
J. E. Nuss, J. K. Amaning, C. E. Bailey et al., “Oxidative modification and aggregation of creatine kinase from aged mouse skeletal muscle,” Aging, vol. 1, no. 6, pp. 557–572, 2009.View at: Google Scholar
B. S. Berlett and E. R. Stadtman, “Protein oxidation in aging, disease, and oxidative stress,” The Journal of Biological Chemistry, vol. 272, no. 33, pp. 20313–20316, 1997.View at: Publisher Site | Google Scholar
R. L. Levine and E. R. Stadtman, “Oxidative modification of proteins during aging,” Experimental Gerontology, vol. 36, no. 9, pp. 1495–1502, 2001.View at: Publisher Site | Google Scholar
T. Grune, B. Catalgol, and T. Jung, “Removal of oxidized proteins,” in Protein Oxidation and Aging, John Wiley & Sons, Hoboken, NJ, USA, 2012.View at: Google Scholar
R. G. McCoy and K. S. Nair, “The 2010 ESPEN Sir David Cuthbertson lecture: new and old proteins: clinical implications,” Clinical Nutrition, vol. 32, no. 5, pp. 728–736, 2013.View at: Publisher Site | Google Scholar
M. A. Baraibar, R. Ladouce, and B. Friguet, “Proteomic quantification and identification of carbonylated proteins upon oxidative stress and during cellular aging,” Journal of Proteomics, vol. 92, pp. 63–70, 2013.View at: Publisher Site | Google Scholar
A. Jaleel, G. C. Henderson, B. J. Madden et al., “Identification of de novo synthesized and relatively older proteins: accelerated oxidative damage to de novo synthesized apolipoprotein A-1 in type 1 diabetes,” Diabetes, vol. 59, no. 10, pp. 2366–2374, 2010.View at: Publisher Site | Google Scholar
A. S. Krolewski, E. J. Kosinski, J. H. Warram et al., “Magnitude and determinants of coronary artery disease in juvenile-onset, insulin-dependent diabetes mellitus,” The American Journal of Cardiology, vol. 59, no. 8, pp. 750–755, 1987.View at: Publisher Site | Google Scholar
A. R. Hipkiss, P. L. Carmichael, and B. Zimmermann, “Metabolism of crystallin fragments in cell-free extracts of bovine lens: effects of ageing and oxygen free-radicals,” Acta Biologica Hungarica, vol. 42, no. 1–3, pp. 243–263, 1991.View at: Google Scholar
A. R. Hipkiss, “Accumulation of altered proteins and ageing: causes and effects,” Experimental Gerontology, vol. 41, no. 5, pp. 464–473, 2006.View at: Publisher Site | Google Scholar
A. R. Hipkiss, “Error-protein metabolism and ageing,” Biogerontology, vol. 10, no. 4, pp. 523–529, 2009.View at: Publisher Site | Google Scholar
E. R. Stadtman, “Protein oxidation and aging,” Science, vol. 257, no. 5074, pp. 1220–1224, 1992.View at: Publisher Site | Google Scholar
R. F. Rosenberger, “Senescence and the accumulation of abnormal proteins,” Mutation Research, vol. 256, no. 2–6, pp. 255–262, 1991.View at: Publisher Site | Google Scholar
E. R. Stadtman and R. L. Levine, “Chemical modification of proteins by reactive oxygen species,” in Redox Proteomics: From Protein Modifications to Cellular Dysfunction and Diseases, I. Dalle-Donne, A. Scaloni, and D. A. Butterfield, Eds., pp. 3–23, Wiley-Interscience, Hoboken, NJ, USA, 2006.View at: Google Scholar
B. P. Yu, “Why calorie restriction would work for human longevity,” Biogerontology, vol. 7, no. 3, pp. 179–182, 2006.View at: Publisher Site | Google Scholar
R. A. Dunlop, R. T. Dean, and K. J. Rodgers, “The impact of specific oxidized amino acids on protein turnover in J774 cells,” Biochemical Journal, vol. 410, no. 1, pp. 131–140, 2008.View at: Publisher Site | Google Scholar
N. Abello, H. A. M. Kerstjens, D. S. Postma, and R. Bischoff, “Protein tyrosine nitration: selectivity, physicochemical and biological consequences, denitration, and proteomics methods for the identification of tyrosine-nitrated proteins,” Journal of Proteome Research, vol. 8, no. 7, pp. 3222–3238, 2009.View at: Publisher Site | Google Scholar
P. Pacher, J. S. Beckman, and L. Liaudet, “Nitric oxide and peroxynitrite in health and disease,” Physiological Reviews, vol. 87, no. 1, pp. 315–424, 2007.View at: Publisher Site | Google Scholar
M. B. Feeney and C. Schöneich, “Tyrosine modifications in aging,” Antioxidants & Redox Signaling, vol. 17, no. 11, pp. 1571–1579, 2012.View at: Publisher Site | Google Scholar
D. Davies, “A quiet life with proteins,” Annual Review of Biophysics and Biomolecular Structure, vol. 34, pp. 1–20, 2005.View at: Publisher Site | Google Scholar
H. Esterbauer, R. J. Schaur, and H. Zollner, “Chemistry and Biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes,” Free Radical Biology and Medicine, vol. 11, no. 1, pp. 81–128, 1991.View at: Publisher Site | Google Scholar
Y. Miura, Y. Sato, Y. Arai et al., “Proteomic analysis of plasma proteins in Japanese semisuper centenarians,” Experimental Gerontology, vol. 46, no. 1, pp. 81–85, 2011.View at: Publisher Site | Google Scholar
G. Barja, “Updating the mitochondrial free radical theory of aging: an integrated view, key aspects, and confounding concepts,” Antioxidants & Redox Signaling, vol. 19, no. 12, pp. 1420–1445, 2013.View at: Publisher Site | Google Scholar
S. Ghosh, R. Lertwattanarak, N. Lefort et al., “Reduction in reactive oxygen species production by mitochondria from elderly subjects with normal and impaired glucose tolerance,” Diabetes, vol. 60, no. 8, pp. 2051–2060, 2011.View at: Publisher Site | Google Scholar
E. K. Ahmed, A. Rogowska-Wrzesinska, P. Roepstorff, A.-L. Bulteau, and B. Friguet, “Protein modification and replicative senescence of WI-38 human embryonic fibroblasts,” Aging Cell, vol. 9, no. 2, pp. 252–272, 2010.View at: Publisher Site | Google Scholar
M. A. Baraibar, J. Hyzewicz, A. Rogowska-Wrzesinska et al., “Oxidative stress-induced proteome alterations target different cellular pathways in human myoblasts,” Free Radical Biology and Medicine, vol. 51, no. 8, pp. 1522–1532, 2011.View at: Publisher Site | Google Scholar
J. M. Held and B. W. Gibson, “Regulatory control or oxidative damage? Proteomic approaches to interrogate the role of cysteine oxidation status in biological processes,” Molecular & Cellular Proteomics, vol. 11, no. 4, Article ID R111.013037, 2012.View at: Publisher Site | Google Scholar
B. Moosmann and C. Behl, “Mitochondrially encoded cysteine predicts animal lifespan,” Aging Cell, vol. 7, no. 1, pp. 32–46, 2008.View at: Publisher Site | Google Scholar
A. D. Kline, I. D. Krantz, A. Sommer et al., “Cornelia de lange syndrome: clinical review, diagnostic and scoring systems, and anticipatory guidance,” American Journal of Medical Genetics A, vol. 146, no. 20, pp. 1287–1296, 2008.View at: Publisher Site | Google Scholar
A. Gimigliano, L. Mannini, L. Bianchi et al., “Proteomic profile identifies dysregulated pathways in Cornelia de Lange syndrome cells with distinct mutations in SMC1A and SMC3 genes,” Journal of Proteome Research, vol. 11, no. 12, pp. 6111–6123, 2012.View at: Publisher Site | Google Scholar
S. Okumura, J.-I. Kawabe, A. Yatani et al., “Type 5 adenylyl cyclase disruption alters not only sympathetic but also parasympathetic and calcium-mediated cardiac regulation,” Circulation Research, vol. 93, no. 4, pp. 364–371, 2003.View at: Publisher Site | Google Scholar
L. Yan, D. E. Vatner, J. P. O'Connor et al., “Type 5 adenylyl cyclase disruption increases longevity and protects against stress,” Cell, vol. 130, no. 2, pp. 247–258, 2007.View at: Publisher Site | Google Scholar
A. Navarro, M. J. Sánchez del Pino, C. Gómez, J. L. Peralta, and A. Boveris, “Behavioral dysfunction, brain oxidative stress, and impaired mitochondrial electron transfer in aging mice,” American Journal of Physiology, vol. 282, no. 4, pp. R985–R992, 2002.View at: Publisher Site | Google Scholar
M. Perluigi, F. di Domenico, A. Giorgi et al., “Redox proteomics in aging rat brain: involvement of mitochondrial reduced glutathione status and mitochondrial protein oxidation in the aging process,” Journal of Neuroscience Research, vol. 88, no. 16, pp. 3498–3507, 2010.View at: Publisher Site | Google Scholar
S. Yang, T. Liu, S. Li et al., “Comparative proteomic analysis of brains of naturally aging mice,” Neuroscience, vol. 154, no. 3, pp. 1107–1120, 2008.View at: Publisher Site | Google Scholar
H. D. VanGuilder and W. M. Freeman, “The hippocampal neuroproteome with aging and cognitive decline: past progress and future directions,” Frontiers in Aging Neuroscience, vol. 3, article 8, 2011.View at: Publisher Site | Google Scholar
J.-L. Yang, L. Weissman, V. A. Bohr, and M. P. Mattson, “Mitochondrial DNA damage and repair in neurodegenerative disorders,” DNA Repair, vol. 7, no. 7, pp. 1110–1120, 2008.View at: Publisher Site | Google Scholar
W. R. Markesbery, “Oxidative stress hypothesis in Alzheimer's disease,” Free Radical Biology and Medicine, vol. 23, no. 1, pp. 134–147, 1997.View at: Publisher Site | Google Scholar
M. A. Korolainen, G. Goldsteins, I. Alafuzoff, J. Koistinaho, and T. Pirttilä, “Proteomic analysis of protein oxidation in Alzheimer's disease brain,” Electrophoresis, vol. 23, no. 19, pp. 3428–3433, 2002.View at: Google Scholar
A. Castegna, M. Aksenov, M. Aksenova et al., “Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part I: creatine kinase BB, glutamine synthase, and ubiquitin carboxy-terminal hydrolase L-1,” Free Radical Biology and Medicine, vol. 33, no. 4, pp. 562–571, 2002.View at: Publisher Site | Google Scholar
A. Castegna, M. Aksenov, V. Thongboonkerd et al., “Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part II: dihydropyrimidinase-related protein 2, α-enolase and heat shock cognate 71,” Journal of Neurochemistry, vol. 82, no. 6, pp. 1524–1532, 2002.View at: Publisher Site | Google Scholar
D. A. Butterfield and C. M. Lauderback, “Lipid peroxidation and protein oxidation in Alzheimer's disease brain: potential causes and consequences involving amyloid β-peptide-associated free radical oxidative stress,” Free Radical Biology and Medicine, vol. 32, no. 11, pp. 1050–1060, 2002.View at: Publisher Site | Google Scholar
M. A. Korolainen, T. A. Nyman, P. Nyyssönen, E. S. Hartikainen, and T. Pirttilä, “Multiplexed proteomic analysis of oxidation and concentrations of cerebrospinal fluid proteins in Alzheimer disease,” Clinical Chemistry, vol. 53, no. 4, pp. 657–665, 2007.View at: Publisher Site | Google Scholar
O. Weinreb, N. Drigues, Y. Sagi, A. Z. Reznick, T. Amit, and M. B. H. Youdim, “The application of proteomics and genomics to the study of age-related neurodegeneration and neuroprotection,” Antioxidants & Redox Signaling, vol. 9, no. 2, pp. 169–179, 2007.View at: Publisher Site | Google Scholar
Y. H. Chung, C. M. Shin, K. M. Joo, M. J. Kim, and C. I. Cha, “Immunohistochemical study on the distribution of nitrotyrosine and neuronal nitric oxide synthase in aged rat cerebellum,” Brain Research, vol. 951, no. 2, pp. 316–321, 2002.View at: Publisher Site | Google Scholar
E. Siles, E. Martínez-Lara, A. Cauelo et al., “Age-related changes of the nitric oxide system in the rat brain,” Brain Research, vol. 956, no. 2, pp. 385–392, 2002.View at: Publisher Site | Google Scholar
D. Boyd-Kimball, R. Sultana, H. F. Poon et al., “γ-glutamylcysteine ethyl ester protection of proteins from Aβ(1–42)-mediated oxidative stress in neuronal cell culture: a proteomics approach,” Journal of Neuroscience Research, vol. 79, no. 5, pp. 707–713, 2005.View at: Publisher Site | Google Scholar
J. Drake, J. Kanski, S. Varadarajan, M. Tsoras, and D. A. Butterfield, “Elevation of brain glutathione by γ-glutamylcysteine ethyl ester protects against peroxynitrite-induced oxidative stress,” Journal of Neuroscience Research, vol. 68, no. 6, pp. 776–784, 2002.View at: Publisher Site | Google Scholar
J. P. Bolaños, S. J. R. Heales, J. M. Land, and J. B. Clark, “Effect of peroxynitrite on the mitochondrial respiratory chain: differential susceptibility of neurones and astrocytes in primary culture,” Journal of Neurochemistry, vol. 64, no. 5, pp. 1965–1972, 1995.View at: Publisher Site | Google Scholar
S. Desagher, J. Glowinski, and J. Premont, “Astrocytes protect neurons from hydrogen peroxide toxicity,” Journal of Neuroscience, vol. 16, no. 8, pp. 2553–2562, 1996.View at: Google Scholar
J. Tanaka, K. Toku, B. Zhang, K. Ishihara, M. Sakanaka, and N. Maeda, “Astrocytes prevent neuronal death induced by reactive oxygen and nitrogen species,” Glia, vol. 28, no. 2, pp. 85–96, 1999.View at: Google Scholar
S. B. Hollensworth, C.-C. Shen, J. E. Sim, D. R. Spitz, G. L. Wilson, and S. P. Ledoux, “Glial cell type-specific responses to menadione-induced oxidative stress,” Free Radical Biology and Medicine, vol. 28, no. 8, pp. 1161–1174, 2000.View at: Publisher Site | Google Scholar
Y. Miura, M. Kano, K. Abe, S. Urano, S. Suzuki, and T. Toda, “Age-dependent variations of cell response to oxidative stress: proteomic approach to protein expression and phosphorylation,” Electrophoresis, vol. 26, no. 14, pp. 2786–2796, 2005.View at: Publisher Site | Google Scholar
H. Oxenham and N. Sharpe, “Cardiovascular aging and heart failure,” European Journal of Heart Failure, vol. 5, no. 4, pp. 427–434, 2003.View at: Publisher Site | Google Scholar
J. E. Grant, A. D. Bradshaw, J. H. Schwacke, C. F. Baicu, M. R. Zile, and K. L. Schey, “Quantification of protein expression changes in the aging left ventricle of Rattus norvegicus,” Journal of Proteome Research, vol. 8, no. 9, pp. 4252–4263, 2009.View at: Publisher Site | Google Scholar
Q. Dai, G. P. Escobar, K. W. Hakala, J. M. Lambert, S. T. Weintraub, and M. L. Lindsey, “The left ventricle proteome differentiates middle-aged and old left ventricles in mice,” Journal of Proteome Research, vol. 7, no. 2, pp. 756–765, 2008.View at: Publisher Site | Google Scholar
M. R. Richardson, X. Lai, S. B. Mason, S. J. Miller, and F. A. Witzmann, “Differential protein expression during aging in ventricular myocardium of Fischer 344 × Brown Norway hybrid rats,” Experimental Gerontology, vol. 43, no. 10, pp. 909–918, 2008.View at: Publisher Site | Google Scholar
M. L. Lindsey, D. K. Goshorn, S. Comte-Walters et al., “A multidimensional proteomic approach to identify hypertrophy-associated proteins,” Proteomics, vol. 6, no. 7, pp. 2225–2235, 2006.View at: Publisher Site | Google Scholar
S. J. Hong, G. Gokulrangan, and C. Schöneich, “Proteomic analysis of age dependent nitration of rat cardiac proteins by solution isoelectric focusing coupled to nanoHPLC tandem mass spectrometry,” Experimental Gerontology, vol. 42, no. 7, pp. 639–651, 2007.View at: Publisher Site | Google Scholar
J. Kanski, M. A. Alterman, and C. Schöneich, “Proteomic identification of age-dependent protein nitration in rat skeletal muscle,” Free Radical Biology and Medicine, vol. 35, no. 10, pp. 1229–1239, 2003.View at: Publisher Site | Google Scholar
J. Kanski, A. Behring, J. Pelling, and C. Schöneich, “Proteomic identification of 3-nitrotyrosine-containing rat cardiac proteins: effects of biological aging,” American Journal of Physiology, vol. 288, no. 1, pp. H371–H381, 2005.View at: Publisher Site | Google Scholar
J. M. Rifkind and E. Nagababu, “Hemoglobin redox reactions and red blood cell aging,” Antioxidants & Redox Signaling, vol. 18, no. 17, pp. 2274–2283, 2013.View at: Publisher Site | Google Scholar
N. Romero and R. Radi, “Hemoglobin and red blood cells as tools for studying peroxynitrite biochemistry,” Methods in Enzymology, vol. 396, pp. 229–245, 2005.View at: Publisher Site | Google Scholar
G. J. C. G. M. Bosman, J. M. Werre, F. L. A. Willekens, and V. M. J. Novotný, “Erythrocyte ageing in vivo and in vitro: structural aspects and implications for transfusion,” Transfusion Medicine, vol. 18, no. 6, pp. 335–347, 2008.View at: Publisher Site | Google Scholar
S. Rinalducci, G. M. D'Amici, B. Blasi, S. Vaglio, G. Grazzini, and L. Zolla, “Peroxiredoxin-2 as a candidate biomarker to test oxidative stress levels of stored red blood cells under blood bank conditions,” Transfusion, vol. 51, no. 7, pp. 1439–1449, 2011.View at: Publisher Site | Google Scholar
M. K. Ha, J. S. Cho, O.-R. Baik, L. K. Hoon, H.-S. Koo, and K. Y. Chung, “Caenorhabditis elegans as a screening tool for the endothelial cell-derived putative aging-related proteins detected by proteomic analysis,” Proteomics, vol. 6, no. 11, pp. 3339–3351, 2006.View at: Publisher Site | Google Scholar
A. L. Fisher, K. E. Page, G. J. Lithgow, and L. Nash, “The Caenorhabditis elegans K10C2.4 gene encodes a member of the fumarylacetoacetate hydrolase family: a Caenorhabditis elegans model of type I tyrosinemia,” The Journal of Biological Chemistry, vol. 283, no. 14, pp. 9127–9135, 2008.View at: Publisher Site | Google Scholar
L. M. Jones, K. Staffa, S. Perally, E. J. LaCourse, P. M. Brophy, and J. V. Hamilton, “Proteomic analyses of Caenorhabditis elegans dauer larvae and long-lived daf-2 mutants implicates a shared detoxification system in longevity assurance,” Journal of Proteome Research, vol. 9, no. 6, pp. 2871–2881, 2010.View at: Publisher Site | Google Scholar
C. Kumsta, M. Thamsen, and U. Jakob, “Effects of oxidative stress on behavior, physiology, and the redox thiol proteome of Caenorhabditis elegans,” Antioxidants & Redox Signaling, vol. 14, no. 6, pp. 1023–1037, 2011.View at: Publisher Site | Google Scholar
K. D. Arczewska, G. G. Tomazella, J. M. Lindvall et al., “Active transcriptomic and proteomic reprogramming in the C. elegans nucleotide excision repair mutant xpa-1,” Nucleic Acids Research, vol. 41, no. 10, pp. 5368–5381, 2013.View at: Publisher Site | Google Scholar
H. Nabeshi, S. Oikawa, S. Inoue, K. Nishino, and S. Kawanishi, “Proteomic analysis for protein carbonyl as an indicator of oxidative damage in senescence-accelerated mice,” Free Radical Research, vol. 40, no. 11, pp. 1173–1181, 2006.View at: Publisher Site | Google Scholar
L. Zhu, J. Yu, Q. Shi et al., “Strain-and age-related alteration of proteins in the brain of SAMP8 and SAMR1 mice,” Journal of Alzheimer's Disease, vol. 23, no. 4, pp. 641–654, 2011.View at: Publisher Site | Google Scholar
B. A. Soreghan, F. Yang, S. N. Thomas, J. Hsu, and A. J. Yang, “High-throughput proteomic-based identification of oxidatively induced protein carbonylation in mouse brain,” Pharmaceutical Research, vol. 20, no. 11, pp. 1713–1720, 2003.View at: Publisher Site | Google Scholar
E. A. Stoll, W. Cheung, A. M. Mikheev et al., “Aging neural progenitor cells have decreased mitochondrial content and lower oxidative metabolism,” The Journal of Biological Chemistry, vol. 286, no. 44, pp. 38592–38601, 2011.View at: Publisher Site | Google Scholar
H. Amelina, M. O. D. Sjödin, J. Bergquist, and S. Cristobal, “Quantitative subproteomic analysis of age-related changes in mouse liver peroxisomes by iTRAQ LC-MS/MS,” Journal of Chromatography B, vol. 879, no. 30, pp. 3393–3400, 2011.View at: Publisher Site | Google Scholar
H. Amelina and S. Cristobal, “Proteomic study on gender differences in aging kidney of mice,” Proteome Science, vol. 7, article 16, 2009.View at: Publisher Site | Google Scholar
J. R. Peinado, P. M. Quirós, M. R. Pulido et al., “Proteomic profiling of adipose tissue from Zmpste24-/- mice, a model of lipodystrophy and premature aging, reveals major changes in mitochondrial function and vimentin processing,” Molecular & Cellular Proteomics, vol. 10, no. 11, Article ID M111.008094, 2011.View at: Publisher Site | Google Scholar
H. S. Smallwood, D. López-Ferrer, and T. C. Squier, “Aging enhances the production of reactive oxygen species and bactericidal activity in peritoneal macrophages by upregulating classical activation pathways,” Biochemistry, vol. 50, no. 45, pp. 9911–9922, 2011.View at: Publisher Site | Google Scholar
M. Santos-González, J. López-Miranda, F. Pérez-Jiménez, P. Navas, and J. M. Villalba, “Dietary oil modifies the plasma proteome during aging in the rat,” Age, vol. 34, no. 2, pp. 341–358, 2012.View at: Publisher Site | Google Scholar
C. H. Kim, Y. Zou, D. H. Kim, N. D. Kim, B. P. Yu, and H. Y. Chung, “Proteomic analysis of nitrated and 4-hydroxy-2-nonenal-modified serum proteins during aging,” The Journals of Gerontology A, vol. 61, no. 4, pp. 332–338, 2006.View at: Google Scholar
G. Gokulrangan, A. Zaidi, M. L. Michaelis, and C. Schöneich, “Proteomic analysis of protein nitration in rat cerebellum: effect of biological aging,” Journal of Neurochemistry, vol. 100, no. 6, pp. 1494–1504, 2007.View at: Publisher Site | Google Scholar
S. Argüelles, M. Cano, A. Machado, and A. Ayala, “Effect of aging and oxidative stress on elongation factor-2 in hypothalamus and hypophysis,” Mechanisms of Ageing and Development, vol. 132, no. 1-2, pp. 55–64, 2011.View at: Publisher Site | Google Scholar
H.-J. Kim, B.-R. Ji, J.-S. Kim, H.-N. Lee, D.-H. Ha, and C.-W. Kim, “Proteomic analysis of proteins associated with cellular senescence by calorie restriction in mesenchymal stem cells,” In Vitro Cellular & Developmental Biology, vol. 48, no. 3, pp. 186–195, 2012.View at: Publisher Site | Google Scholar
X. Gu, N. J. Neric, J. S. Crabb et al., “Age-related changes in the retinal pigment epithelium (RPE),” PLoS ONE, vol. 7, no. 6, Article ID e38673, 2012.View at: Publisher Site | Google Scholar
H. Lee, H. Arnouk, S. Sripathi et al., “Prohibitin as an oxidative stress biomarker in the eye,” International Journal of Biological Macromolecules, vol. 47, no. 5, pp. 685–690, 2010.View at: Publisher Site | Google Scholar
A. Valle, J. Sastre-Serra, P. Roca, and J. Oliver, “Modulation of white adipose tissue proteome by aging and calorie restriction,” Aging Cell, vol. 9, no. 5, pp. 882–894, 2010.View at: Publisher Site | Google Scholar
J. Kanski, S. J. Hong, and C. Schöneich, “Proteomic analysis of protein nitration in aging skeletal muscle and identification of nitrotyrosine-containing sequences in vivo by nanoelectrospray ionization tandem mass spectrometry,” The Journal of Biological Chemistry, vol. 280, no. 25, pp. 24261–24266, 2005.View at: Publisher Site | Google Scholar
I. Piec, A. Listrat, J. Alliot, C. Chambon, R. G. Taylor, and D. Bechet, “Differential proteome analysis of aging in rat skeletal muscle,” FASEB Journal, vol. 19, no. 9, pp. 1143–1145, 2005.View at: Publisher Site | Google Scholar
K. O'Connell and K. Ohlendieck, “Proteomic DIGE analysis of the mitochondria-enriched fraction from aged rat skeletal muscle,” Proteomics, vol. 9, no. 24, pp. 5509–5524, 2009.View at: Publisher Site | Google Scholar
E. M. de Waal, H. Liang, A. Pierce, R. T. Hamilton, R. Buffenstein, and A. R. Chaudhuri, “Elevated protein carbonylation and oxidative stress do not affect protein structure and function in the long-living naked-mole rat: a proteomic approach,” Biochemical and Biophysical Research Communications, vol. 434, no. 4, pp. 815–819, 2013.View at: Publisher Site | Google Scholar
G.-J. Jiang, K. Wang, D.-Q. Miao et al., “Protein profile changes during porcine oocyte aging and effects of caffeine on protein expression patterns,” PLoS ONE, vol. 6, no. 12, Article ID e28996, 2011.View at: Publisher Site | Google Scholar
W. O. Opii, G. Joshi, E. Head et al., “Proteomic identification of brain proteins in the canine model of human aging following a long-term treatment with antioxidants and a program of behavioral enrichment: relevance to Alzheimer's disease,” Neurobiology of Aging, vol. 29, no. 1, pp. 51–70, 2008.View at: Publisher Site | Google Scholar
P. Gromov, G. L. Skovgaard, H. Palsdottir, I. Gromova, M. Østergaard, and J. E. Celis, “Protein profiling of the human epidermis from the elderly reveals up-regulation of a signature of interferon--induced polypeptides that includes manganese-superoxide dismutase and the p85β subunit of phosphatidylinositol 3-kinase,” Molecular & Cellular Proteomics, vol. 2, no. 2, pp. 70–84, 2003.View at: Publisher Site | Google Scholar
L. Xie, G. Tsaprailis, and Q. M. Chen, “Proteomic identification of insulin-like growth factor-binding protein-6 induced by sublethal H2O2 stress from human diploid fibroblasts,” Molecular & Cellular Proteomics, vol. 4, no. 9, pp. 1273–1283, 2005.View at: Publisher Site | Google Scholar
L. Xie, R. Pandey, B. Xu, G. Tsaprailis, and Q. M. Chen, “Genomic and proteomic profiling of oxidative stress response in human diploid fibroblasts,” Biogerontology, vol. 10, no. 2, pp. 125–151, 2009.View at: Publisher Site | Google Scholar
M. Li, Z.-Q. Xiao, Z.-C. Chen et al., “Proteomic analysis of the aging-related proteins in human normal colon epithelial tissue,” Journal of Biochemistry and Molecular Biology, vol. 40, no. 1, pp. 72–81, 2007.View at: Google Scholar
G. Kasper, L. Mao, S. Geissler et al., “Insights into mesenchymal stem cell aging: involvement of antioxidant defense and actin cytoskeleton,” Stem Cells, vol. 27, no. 6, pp. 1288–1297, 2009.View at: Publisher Site | Google Scholar
H. Lans and W. Vermeulen, “Nucleotide excision repair in Caenorhabditis elegans,” Molecular Biology International, vol. 2011, Article ID 542795, 12 pages, 2011.View at: Publisher Site | Google Scholar
M. Pallas, A. Camins, M. A. Smith, G. Perry, H.-G. Lee, and G. Casadesus, “From aging to Alzheimer's disease: unveiling “the switch” with the senescence-accelerated mouse model (SAMP8),” Journal of Alzheimer's Disease, vol. 15, no. 4, pp. 615–624, 2008.View at: Google Scholar
L. Packer, S. Roy, and C. K. Sen, “Alpha-lipoic acid: a metabolic antioxidant and potential redox modulator of transcription,” Advances in Pharmacology, vol. 38, pp. 79–101, 1997.View at: Google Scholar
L. Packer, H. J. Tritschler, and K. Wessel, “Neuroprotection by the metabolic antioxidant α-lipoic acid,” Free Radical Biology and Medicine, vol. 22, no. 1-2, pp. 359–378, 1997.View at: Publisher Site | Google Scholar
H. F. Poon, S. A. Farr, V. Thongboonkerd et al., “Proteomic analysis of specific brain proteins in aged SAMP8 mice treated with alpha-lipoic acid: implications for aging and age-related neurodegenerative disorders,” Neurochemistry International, vol. 46, no. 2, pp. 159–168, 2005.View at: Publisher Site | Google Scholar
K. N. Lewis, J. Mele, J. D. Hayes, and R. Buffenstein, “Nrf2, a guardian of healthspan and gatekeeper of species longevity,” Integrative & Comparative Biology, vol. 50, no. 5, pp. 829–843, 2010.View at: Publisher Site | Google Scholar
K. A. Rodriguez, Y. H. Edrey, P. Osmulski, M. Gaczynska, and R. Buffenstein, “Altered composition of liver proteasome assemblies contributes to enhanced proteasome activity in the exceptionally long-lived naked mole-rat,” PLoS ONE, vol. 7, no. 5, Article ID e35890, 2012.View at: Publisher Site | Google Scholar
D. J. Selkoe, D. S. Bell, M. B. Podlisny, and L. C. Cork, “Conservation of brain amyloid proteins in aged mammals and humans with Alzheimer's disease,” Science, vol. 235, no. 4791, pp. 873–877, 1987.View at: Publisher Site | Google Scholar
B. J. Cummings, E. Head, A. J. Afagh, N. W. Milgram, and C. W. Cotman, “β-amyloid accumulation correlates with cognitive dysfunction in the aged canine,” Neurobiology of Learning and Memory, vol. 66, no. 1, pp. 11–23, 1996.View at: Publisher Site | Google Scholar
E. Head and R. Torp, “Insights into Aβ and presenilin from a canine model of human brain aging,” Neurobiology of Disease, vol. 9, no. 1, pp. 1–10, 2002.View at: Publisher Site | Google Scholar
E. Head, R. McCleary, F. F. Hahn, N. W. Milgram, and C. W. Cotman, “Region-specific age at onset of β-amyloid in dogs,” Neurobiology of Aging, vol. 21, no. 1, pp. 89–96, 2000.View at: Publisher Site | Google Scholar
S. Austad, “Advances in vertebrate aging research 2007,” Aging Cell, vol. 7, no. 2, pp. 119–124, 2008.View at: Publisher Site | Google Scholar
R. A. Miller, D. E. Harrison, C. M. Astle et al., “An aging interventions testing program: study design and interim report,” Aging Cell, vol. 6, no. 4, pp. 565–575, 2007.View at: Publisher Site | Google Scholar